Compugen (CGEN) Shares Outstanding (Diluted Average) (2010 - 2025)

Compugen recorded quarterly Shares Outstanding (Diluted Average) of $38.9 million in Q4 2013, up 7.23% quarter-over-quarter from $36.2 million in Q4 2012, and up 7.23% year-over-year from $36.2 million in Q4 2012.

Compugen's Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $38.9 million for Q4 2013.

  • In Q4 2013, Shares Outstanding (Diluted Average) rose 7.23% year-over-year to $38.9 million; the TTM figure through Dec 2013 stood at $38.9 million (up 7.23% YoY), while the FY2013 annual figure was $38.9 million, up 7.23% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $38.9 million for Q4 2013 at Compugen, up from $36.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $38.9 million in Q4 2013 to a low of $33.3 million in Q4 2010.
  • A 4-year average of $35.7 million and a median of $35.3 million in 2011 frame the typical range for Shares Outstanding (Diluted Average).
  • Across the five-year window, Shares Outstanding (Diluted Average) climbed 2.98% in 2011 and grew 7.23% in 2013, its largest moves.
  • Compugen's Shares Outstanding (Diluted Average) stood at $33.3 million in 2010, then advanced by 2.98% to $34.3 million in 2011, then increased by 5.75% to $36.2 million in 2012, then advanced by 7.23% to $38.9 million in 2013.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $38.9 million, $36.2 million, and $34.3 million for Q4 2013, Q4 2012, and Q4 2011 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 160.00
Jun 30, 2024 100.00
Jun 30, 2023 210.00
Jun 30, 2022 220.00
Jun 30, 2021 230.00
Mar 31, 2019 60.02 Mn
Mar 31, 2018 51.98 Mn
Mar 31, 2017 51.13 Mn
Dec 31, 2015 50.53 Mn
Jun 30, 2015 50.41 Mn
Dec 31, 2014 50.14 Mn
Jun 30, 2014 49.80 Mn
Dec 31, 2013 42.74 Mn
Sep 30, 2013 39.15 Mn
Jun 30, 2013 39.14 Mn
Dec 31, 2012 36.25 Mn
Sep 30, 2012 36.80 Mn
Jun 30, 2012 130.00
Dec 31, 2011 34.28 Mn
Sep 30, 2011 34.49 Mn
Dec 31, 2010 33.28 Mn